These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 5056542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"].
    Gheorghescu B, Steflea D, Jovin G, Suseanu I.
    Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of cholerelics on bile flow in diseases of the liver and of the bile ducts (author's transl)].
    Bode JC, Strohmeyer G.
    Leber Magen Darm; 1974 Apr; 4(2):65-71. PubMed ID: 4828906
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M, Ancona A, Palmieri R, Palmieri G, Zambruno E.
    Clin Ter; 1980 Dec 31; 95(6):637-54. PubMed ID: 7011665
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H, Weber D, Wotzka R.
    Med Klin; 1969 Dec 31; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of xylite on hepatic and pancreatic function in biliary pathology].
    Rafes IuI, Sheleketina II, Voroteliak VS, Kulikova ZS, Mel'nichenko LIa.
    Vrach Delo; 1972 Feb 31; 2():10-4. PubMed ID: 5084716
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of furosemide on the liver function].
    Pickert H, Müller K, Henning H.
    Ther Ggw; 1966 Feb 31; 105(2):250-4. PubMed ID: 5915868
    [No Abstract] [Full Text] [Related]

  • 11. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
    Cremoncini C, Tominz L.
    Minerva Med; 1968 Oct 13; 59(82):4359-68. PubMed ID: 5683717
    [No Abstract] [Full Text] [Related]

  • 12. [Thiomesterone and liver function].
    Pickert H.
    Med Klin; 1968 Aug 02; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A, Castel A, Bloch J.
    Therapeutique; 1970 Dec 02; 46(10):993-5. PubMed ID: 5511936
    [No Abstract] [Full Text] [Related]

  • 14. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V.
    Vutr Boles; 1973 Dec 02; 12(2):69-73. PubMed ID: 4713058
    [No Abstract] [Full Text] [Related]

  • 15. [Clinico-statistical study of the therapeutic activity of coenzyme A in various hepatopathies].
    Ruberti A, Tobaldin G, Montanari MG, Castellani P.
    Clin Ter; 1971 May 31; 57(4):309-42. PubMed ID: 5110947
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of a new choleretic administered in normal and high doses to patients with chronic hepatocholecytopathies].
    Petracca EG, Cavazzuti C.
    Clin Ter; 1983 Oct 31; 107(2):109-19. PubMed ID: 6362962
    [No Abstract] [Full Text] [Related]

  • 17. [Stea 16].
    Med Chir Dig; 1972 Oct 31; 1(3):Suppl:35-40. PubMed ID: 5080085
    [No Abstract] [Full Text] [Related]

  • 18. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R, Arcangeli A, Salvadori G, Smorlesi C, Di Perri T, Auteri A, Boggiano CA, Pippi L, Toti M, Boncompagni P, Angioli D, Caremani M, Magnolfi F, Camarri E, Motta R, Forconi A, Candidi Tommasi A, Lomi M, Soldi A.
    Minerva Med; 1978 Oct 13; 69(48):3283-92. PubMed ID: 724140
    [No Abstract] [Full Text] [Related]

  • 19. [The choleretics].
    Geoffroy H, Dezoteux H.
    Maroc Med; 1967 Jul 13; 47(504):506-11. PubMed ID: 5613355
    [No Abstract] [Full Text] [Related]

  • 20. Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
    Schmidt HH, Manns MP.
    Am J Gastroenterol; 1996 Feb 13; 91(2):406-7. PubMed ID: 8607528
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.